ethyl 2-(pyridin-3-ylmethoxy)acetate 、 1-amino-3-(3,4-dihydroisoquinolin-2(1H)-yl)propan-2-ol 以
乙醇 为溶剂,
反应 1.0h,
以to give the title compound (30 mg, yield: 16.5%) as a white solid的产率得到N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)-2-(pyridin-3-ylmethoxy)acetamide
[EN] PRMT5 INHIBITORS CONTAINING A DIHYDRO- OR TETRAHYDROISOQUINOLINE AND USES THEREOF<br/>[FR] INHIBITEURS DE LA PRMT5 CONTENANT UNE DIHYDRO- OU TÉTRAHYDRO-ISOQUINOLÉINE ET LEURS UTILISATIONS
申请人:EPIZYME INC
公开号:WO2014100730A1
公开(公告)日:2014-06-26
Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5- mediated disorders are also described.
The flexibility–complementarity dichotomy in receptor–ligand interactions
作者:Hongmei Sun、Christopher A. Hunter、Eva Marina Llamas
DOI:10.1039/c4sc03398a
日期:——
Binding affinity does not increase uniformly with preorganization, because there is a trade off between flexibility and fit.
结合亲和力并不随着预组织而均匀增加,因为在灵活性和匹配之间存在权衡。
Substituted isocytosines having histamine H.sub.2 -antagonist activity
申请人:Smith Kline & French Laboratories Limited
公开号:US04154834A1
公开(公告)日:1979-05-15
The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present inventon are 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-(3-pyridylmethyl)-4-py rimidone and 2-[2-(3-bromo-2-pyridylmethylthio)ethylamino]-5-(4-pyridylmethyl)-4-pyrimi done.
The compounds are substituted isocytosines which are histamine H.sub.2 -antagonists. Two specific compounds of the present invention are 2-[2-(5-methyl-4-imidazolylmethylthio)ethylamino]-5-(3-pyridylmethyl)-4-py rimidone and 2-[2-(3-bromo-2-pyridylmethylthio)-ethylamino]-5-(4-pyridylmethyl)-4-pyrim idone.
2-[2-(2-aminoalkyl-4-thiazolylmethylthio)-alkylene]amino-5-aromatic-substit uted alkylene-4-pyrimidones and related compounds, H.sub.2 receptor antagonists, useful in inhibiting gastric acid secretion in mammals.